GPHL and M.U.S.T. work together to develop biopharma industry in GBA

2020-08-12 15:54:57 GPHL GPHL

On August 3rd, a group led by Prof. Liu Liang, President of Macau University of Science and Technology (M.U.S.T.) and member of the Chinese Academy of Engineering, visited GPHL in Guangzhou. Wang Xinhua, President of Guangzhou Medical University, GPHL chairman Li Chuyuan and Li Hong, General Manager of GPHL's subsidiary Guangzhou Baiyunshan Pharmaceutical, attended a symposium with the visiting group.

Prof. Liu Liang attends the symposium.

GPHL leaders and the M.U.S.T. group hold a symposium.

They explored in depth the issue on biopharma project cooperation and expected to develop the biopharma-oriented research and industrialization in the Guangdong-Hong Kong-Macao Greater Bay Area in a complementary manner.

After the symposium, Prof. Liu and his group paid a visit to the Shennong Caotang Museum and the exhibition hall at the Baiyunshan Pharmaceutical General Factory (BPGF). They were impressed with the recent achievements achieved by the museum and BPGF.

GPHL representatives and Prof. Liu’s group pose for a group photo at the Shennong Caotang Museum.

GPHL representatives and Prof. Liu’s group pose for a group photo at the Baiyunshan Pharmaceutical General Factory.

GPHL and M.U.S.T. have enjoyed long-term cooperation and thus established a firm foundation for further cooperation. In 2008, with the help of Guangzhou Baiyun Mountain and Hutchison Whampoa Ltd., the State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology conducted comprehensive evidence based clinical practices and fundamental research on Banlangen Granules. In 2010 the two parties joined hands with a medical team led by Dr. Zhong Nanshan to establish the Guangdong-Macau Joint Research Centre for New Drug Discovery against Respiratory Pathogens.

Government-Industry-University Institute for GPHL's State Key Laboratory of Respiratory Disease

In 2015, GPHL entered into a strategic agreement with GMTCM Park and M.U.S.T., making GPHL the first established company located in the GMTCM Park.

In January of 2020, GPHL established the Guangzhou Pharmaceutical Group (Macau) International Development Co. GPHL also established the Guangzhou Pharmaceutical (Hengqin) Chinese Medicine Industrial Park Co., Ltd. at the GMTCM Park in order to bring more potential opportunities to the expansion of its international HQ for operating different projects in fields such as new drug development, pharmaceutical supply chains and extraction of compounds from Chinese herbs.

Authors: Monica & Michelle

Editors: Olivia & Jerry

NULL